Novel fused heteroaromatic compounds as transforming growth...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/4188 (2006.01) A61P 35/00 (2006.01) C07D 471/04 (2006.01) C07D 513/04 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2517933

Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor ("TGF")-.szlig. signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.

Nouveaux composés hétéroaromatiques condensés ainsi que leurs dérivés, intermédiaires destinés à leur préparation, compositions pharmaceutiques les contenant et leur utilisation comme médicaments. Les composés selon la présente invention sont des inhibiteurs puissants de la voie de transmission de signal du facteur de croissance transformant (TGF)-.beta.. Ils sont utiles dans le traitement de divers états pathologiques associés au TGF, tels que le cancer et les affections de type fibreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel fused heteroaromatic compounds as transforming growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel fused heteroaromatic compounds as transforming growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel fused heteroaromatic compounds as transforming growth... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1580868

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.